Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


 

Star Scientific plans to seek FDA approval for new products

Wed. September 23, 2009; Posted: 02:52 PM
Stocks RSS
Sep 23, 2009 (Richmond Times-Dispatch - McClatchy-Tribune Information Services via COMTEX) -- STSI | Quote | Chart | News | PowerRating -- Star Scientific Inc. wants to be the first company seeking approval from federal regulators to sell so-called "modified-risk" tobacco products with reduced toxins.

The Petersburg-based company, which makes smokeless tobacco products, said yesterday that it plans to ask the Food and Drug Administration next year for approval to market its products as potentially less risky to consumers' health.

Congress passed legislation this year that for the first time gives the FDA authority to regulate tobacco products. The legislation also lets tobacco companies submit products for scientific review by the FDA and approval to be marketed as "modified-risk."

Star did not provide details about any new products, which it said are still in development. Company spokeswoman Sara Machir said one would be similar to the dissolvable, lozenge-like smokeless tobacco products the company now sells under brand names Stonewall and Ariva.

"What would distinguish it is the even significantly lower nitrosamine levels," she said. Nitrosamines are cancer-causing agents considered by some researchers to be the most significant harmful elements in smokeless tobacco.

Star obtained a patent in 2001 for a tobacco-curing process that reduces nitrosamines. In 2001, the company filed a patent-infringement lawsuit against cigarette maker R.J. Reynolds Tobacco Co. A federal jury in Baltimore returned a verdict for Reynolds in June, but Star is seeking a new trial.

Now, Star says it has developed a new method for cultivation, curing and preparation of tobacco that further reduces nitrosamine levels. The company's shares rose 13 percent, or 13 cents, to $1.11 yesterday on the Nasdaq stock market.

Matthew Myers, president of the Campaign for Tobacco-Free Kids, said it is difficult to predict how quickly tobacco companies will come forward to seek approval from the FDA for reduced-risk tobacco products.

The agency must consider the potential broad impact of those products on public health, he said.

"The benefit of the new law is that these decisions will now be based on science from an objective viewpoint," he said.

------

Contact John Reid Blackwell at (804) 775-8123 or jblackwell@timesdispatch.com.

To see more of the Richmond Times-Dispatch, or to subscribe to the newspaper, go
to http://www.timesdispatch.com. Copyright (c) 2009, Richmond Times-Dispatch,
Va. Distributed by McClatchy-Tribune Information Services. For reprints, email
tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send a fax
to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave.,
Suite 303, Glenview, IL 60025, USA.
For full details on Star Scientific Inc. (STSI) click here. Star Scientific Inc. (STSI) has Short Term PowerRatings of 3. Details on Star Scientific Inc. (STSI) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [STSI]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.